Trade Summary

5 days ago, Vu Quan Anh, serving as CFO at Monopar Therapeutics (MNPR), purchased 1,500 shares at $69.95 per share, for a total transaction value of $104,925.00. Following this transaction, Vu Quan Anh now holds 1,500 shares of MNPR.

The trade was executed on Friday, December 26, 2025 and publicly disclosed via SEC Form 4 filing on Monday, December 29, 2025, 3 days after the trade was made.

Monopar Therapeutics operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.